SCHEMBL7657825

SCHEMBL7657825

Cc1ccc(C2(c3ccc(C)cc3)NC(=O)N(CCCN3CCC4(CC3)OC(=O)Nc3ccc(F)cc34)C2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 3/20 0.50
HRH1 P35367 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SIGMAR1 Q99720 8/20 0.42
PLD2 O14939 2/20 0.40
PLD1 Q13393 2/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CNR1 P21554 3/20 0.39
ADRA1A P35348 1/20 0.38
DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7659345 0.90 HRH1 (0.44) CCR2HRH1HRH3TDP1SIGMAR1
SCHEMBL7660411 0.88 HRH1 (0.53) CCR2HRH1HRH3TDP1SIGMAR1
SCHEMBL7657286 0.76 HRH1 (0.51) HRH1HRH3SIGMAR1CNR1ADRA1A
SCHEMBL7656122 0.75 HRH1 (0.43) HRH1HRH3SIGMAR1CNR1ADRA1A
SCHEMBL7653823 0.75 HRH1 (0.56) HRH1HRH3SIGMAR1ADRA1A
SCHEMBL4999332 0.75 CCR2 (0.49) CCR2HRH3TDP1SIGMAR1PLD2
SCHEMBL4999331 0.75 CCR2 (0.49) CCR2HRH3TDP1SIGMAR1PLD2
Hydrochloric Acid SCHEMBL7664647 0.74 HRH1 (0.55) HRH1HRH3SIGMAR1ADRA1A
SCHEMBL13864851 0.73 CCR2 (0.50) CCR2TDP1SIGMAR1PLD2PLD1
SCHEMBL7652519 0.73 ADRA1A (0.40) HRH1HRH3SIGMAR1CNR1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436962-B1 ALPHA 1A ADRENERGIC RECEPTOR ANTAGONISTS; RELIEF FROM BENIGN PROSTATIC HYPERPLASIA BY LESS HINDERED URINE FLOW BY RELAXING SMOOTH MUSCLE TISSUE; WITH A TESTOSTERONE 5-ALPHA REDUCTASE INHIBITOR, FINASTERIDE; ACUTE AND CHRONIC RELIEF MERCK & CO., INC. 2002-08-20 US disclosed